Skip to content

Diagnostic and Prognostic Roles of Procalcitonin and Highly Sensitive C-Reactive Protein in Early Detection of Burn Sepsis

Diagnostic and Prognostic Roles of Procalcitonin and Highly Sensitive C-Reactive Protein in Early Detection of Burn Sepsis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07791030
Enrollment
30
Registered
2026-08-27
Start date
2025-09-01
Completion date
2026-07-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Sepsis, C-Reactive Protein, Diagnostic Role, Early Detection, Highly Sensitive, Procalcitonin, Prognostic Role

Brief summary

This study aimed to evaluate the value of procalcitonin and highly sensitive c-reactive protein as biomarkers for early detection of sepsis in patients with major burns.

Detailed description

Severe burn injuries can cause a marked inflammatory stress response. As the inflammatory state progresses, pro-inflammatory cytokines are continuously released. C reactive protein (CRP) is closely related to the systemic inflammation in its acute phase, as CRP binds to the damaged cell membranes that associates burn injuries and contributes to the associated inflammatory response. Procalcitonin (PCT) a precursor protein for calcitonin, which is synthesized by thyroid C-cells, is yet another biomarker valuable in the sepsis diagnosis.

Interventions

DIAGNOSTIC_TESTMeasurement of Procalcitonin level

Two samples was collected from each patient, one on admission or within the 1st 24 hours of burn and the 2nd were after 3 days.

DIAGNOSTIC_TESTMeasurement of c-reactive protein level

Two samples was collected from each patient, one on admission or within the 1st 24 hours of burn and the 2nd were after 3 days.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age from 3 years to 65 years. * Both sexes. * Patients with major burn (2nd and 3rd degrees of burn).

Exclusion criteria

* Patients with unrealistic expectations. * Patients with inhalational burn injury. * Patients with uncompensated chronic disease e.g. hepatic, renal. * Patients with mental or psychological troubles affecting the study

Design outcomes

Primary

MeasureTime frameDescription
Measurement of c-reactive protein level5 days of burn injuryTwo samples was collected from each patient, one on admission or within the 1st 24 hours of burn and the 2nd were after 3 days.

Secondary

MeasureTime frameDescription
Measurement of procalcitonin level5 days of burn injuryTwo samples were collected from each patient, one on admission or within the 1st 24 hours of burn and the 2nd were after 3 days.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026